We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Rodney Falk MD

Rodney H Falk MD

Director of the Brigham and Women's Hospital Cardiac Amyloidosis Program, Associate Professor of Medicine at Harvard Medical School, Boston, MA
Dr. Falk is Director of the Brigham and Women's Hospital Cardiac Amyloidosis Program and Associate Professor of Medicine at Harvard Medical School.

Recent Contributions to PracticeUpdate:

  1. Tafamidis Effective for Patients With Transthyretin Amyloid Cardiomyopathy
  2. Wild-Type Transthyretin Amyloidosis and Heart Failure

Most Read This Week

Recently Updated